Citation:
Washko GR, Hatabu H, Fernandez I, Nishino M, Okajima Y, Yamashiro T, Ross J, San Jose Estépar R, Diaz A, Himes B, Come C, D'Aco K, Martinez FJ, Han MLK, Lynch DA, Crapo J, Silverman EK, Rosas IO, Hunninghake GM. Statins And Interstitial Lung Abnormalities In Smokers. American journal of respiratory and critical care medicineAmerican journal of respiratory and critical care medicine 2012;185:A5170.
Date Published:
JunAbstract:
Rationale: HMG-CoA reductase inhibitors (statins) have been implicated in the development of interstitial lung disease (ILD) but the relationship between statins and interstitial lung abnormalities (ILA) in smokers has not been assessed.